ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Invesco Variable Rate Preferred ETF

Invesco Variable Rate Preferred ETF (VRP)

24.15
-0.03
(-0.12%)
終了 1月11日 6:00AM
24.15
0.00
(0.00%)
取引時間後: 6:15AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
24.15
買値
-
売値
-
出来高
574,553
24.13 日の範囲 24.1953
23.1429 52 週間の範囲 24.67
時価総額
前日終値
24.18
始値
24.17
最終取引時間
財務取引量
US$ 13,880,482
VWAP
24.1588
平均取引量 (3 か月)
385,285
発行済株式数
72,100,000
配当利回り
-
PER
8.70
1 株当たり利益 (EPS)
2.77
歳入
95.49M
純利益
200.05M

Invesco Variable Rate Preferred ETF について

The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a m... The investment seeks to track the investment results (before fees and expenses) of the Wells Fargo Hybrid and Preferred Securities Floating and Variable Rate Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is a market capitalization-weighted index designed to track the performance of preferred stock, as well as certain types of hybrid securities that are functionally equivalent to preferred stocks, that are issued by U.S.-based or foreign issuers and that pay a floating or variable rate dividend or coupon. It is non-diversified. 詳細を表示

セクター
Mgmt Invt Offices, Open-end
業界
Mgmt Invt Offices, Open-end
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Invesco Variable Rate Preferred ETF is listed in the Mgmt Invt Offices, Open-end sector of the アメリカ証券取引所 with ticker VRP. The last closing price for Invesco Variable Rate Pr... was US$24.18. Over the last year, Invesco Variable Rate Pr... shares have traded in a share price range of US$ 23.1429 to US$ 24.67.

Invesco Variable Rate Pr... currently has 72,100,000 shares in issue. The market capitalisation of Invesco Variable Rate Pr... is US$1.74 billion. Invesco Variable Rate Pr... has a price to earnings ratio (PE ratio) of 8.70.

VRP 最新ニュース

Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

LONDON and RALEIGH, N.C., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verona Pharma plc (Nasdaq: VRNA), please note that all instances of the...

Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD

Primary and secondary lung function endpoints met Results support twice-daily dosing LONDON and RALEIGH, N.C., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona...

Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference

LONDON and RALEIGH, N.C., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma Announces November 2020 Virtual Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases...

Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020

Initiated ENHANCE Phase 3 clinical trials in COPD Completed $200 million private placement Commenced a pilot clinical study in U.S. patients hospitalized with COVID-19 Conference call today at...

Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update...

LONDON and RALEIGH, N.C., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020

LONDON and RALEIGH, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19

LONDON and RALEIGH, N.C., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.14-0.57636887608124.2924.4524.1261877724.2612964SP
4-0.34-1.3883217639924.4924.5624.1255203524.29251037SP
12-0.52-2.1078232671324.6724.6724.1238528524.37592619SP
260.150.6252424.6723.4337833524.25897161SP
520.934.0051679586623.2224.6723.142937391923.97654086SP
156-1.63-6.3227307990725.7825.920.87543399823.19622836SP
260-1.79-6.9005397070225.9426.513.3340149323.74818793SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.81M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.7M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.48M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.58M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.8M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.27M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.84M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.35M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.32M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.21M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.48M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.48M

最近閲覧した銘柄

Delayed Upgrade Clock